2-Coherus

 

Welcome to our virtual exhibit booth!

Coherus_Logo


About Us

Coherus BioSciences is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that can expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010 and headquartered in Silicon Valley, CA, Coherus is composed of a team of industry veterans with decades of experience in pioneering biologics companies. In 2018, the U.S. Food and Drug Administration approved Coherus’ biosimilar UDENYCA® (pegfilgrastim-cbqv). Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs.

www.coherus.com


Click the boxes below to learn more.

Coherus COMPLETE Overview Brochure

UDENYCA HCP Brochure

 

Coherus BioSciences Representatives

Linda Waksmunski
Oncology Account Manager
lwaksmunski@coherus.com
301-569-1688
Bruce Grothen
National Accounts Director
bgrothen@coherus.com
603-440-8770